Myung In Pharmaceutical LTD. (KRX:317450)
South Korea · Delayed Price · Currency is KRW 58,400
-1,100 (-1.85%)
At close: Mar 19, 2026
KRX:317450 Market Cap
KRX:317450 has a market cap or net worth of 852.64 billion as of March 19, 2026.
Market Cap
852.64B
Enterprise Value
378.99B
Revenue
283.31B
Ranking
n/a
PE Ratio
9.12
Stock Price
58,400.00
Market Cap Chart
Since October 1, 2025, KRX:317450's market cap has decreased from 1.78T to 852.64B, a decrease of -52.09%. That is a compound annual growth rate of -79.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 18, 2026 | 868.70B | -13.64% |
| Dec 30, 2025 | 1.01T | -43.48% |
| Oct 1, 2025 | 1.78T | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| G2GBIO | 1.43T |
| Samyang Biopharm | 653.61B |
| ImmuneOncia Therapeutics | 630.40B |
| HEM Pharma | 517.80B |
| CellBion | 352.22B |
| DAE HWA Pharmaceutical | 265.03B |
| NOVAREX | 237.74B |
| Organoidsciences | 186.05B |